BioSpace News Archive

Pregna International Ltd. has furthered its status as a leading women’s healthcare organisation with the launch of its ground-breaking cryotherapy device - CryoPop.

Toronto, Ontario--(Newsfile Corp. - January 14, 2021) - Mindset Pharma Inc. (CSE: MSET) (“Mindset” or the “Company”), a drug discovery and development company focused on developing next generation psychedelic medicines and related technologies, is pleased to announce it has been invited to present at the Canaccord Genuity conference “New Paradigms & Treatment Approaches in Mental Health”, being held February 3-4, 2021.

Mounting incidences of brain tumors across the world are expected to offer a positive impetus to the overall neuroendoscopy market in the years to come.

The next generation sequencing (NGS) market growth will be fostered by the introduction of efficient and advanced sequencing technologies and its extensive application in analyzing DNA.

Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces the appointment of Gaëlle Stadtler as Director of Human Resources

HCPLive® and The American Journal of Managed Care® (AJMC®) are excited to announce the addition of The American Society for Preventive Cardiology (ASPC) to their Strategic Alliance Partnership (SAP) programs.

Today, the U.S. Food and Drug Administration granted the first conditional approval under its expanded authority to KBroVet-CA1 (potassium bromide chewable tablets) to control seizures in dogs with idiopathic epilepsy. Idiopathic epilepsy is a type of seizure disorder without a known cause

As America’s vaccination efforts get off to a slower than anticipated start, The Rockefeller Foundation announces a new $30 million Advance Market Commitment (AMC) to scale up pandemic testing needs and safely reopen schools, communities, and the economy.

PolarityTE, Inc. (Nasdaq: PTE), a company focused on transforming the lives of patients by discovering, designing, and developing a range of regenerative tissue products and biomaterials, announced today the closing of its previously announced registered direct offering.

AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors declared a quarterly dividend of $0.44 per common share, payable March 1, 2021, to stockholders of record at the close of business on February 12, 2021.